COMMUNIQUÉS West-GlobeNewswire

Shuttle Pharma to Participate in the Lytham Partners Spring 2024 Investor Conference on May 30, 2024
22/05/2024
GAITHERSBURG, Md., May 22, 2024 (GLOBE NEWSWIRE) -- Shuttle Pharmaceuticals Holdings, Inc. (Nasdaq: SHPH), a discovery and development stage specialty pharmaceutical company focused on improving the outcomes of cancer [...]
Nyxoah Announces Reduction of the Maximum Amount Available Under its At the-Market Equity Offering Program
22/05/2024
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Reduction of the Maximum Amount Available Under its At-the-Market Equity Offering Program Mont-Saint-Guibert, Belgium – May 22, 2024, 10:10pm CET / 4:10pm ET – [...]
Nyxoah Annonce une Réduction du Montant Maximum Disponible dans le Cadre de son Programme d'Offre d'Actions At-the-Market
22/05/2024
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Réduction du Montant Maximum Disponible dans le Cadre de son Programme d'Offre d'Actions At-the-Market Mont-Saint-Guibert, Belgique – 22 mai 2024, [...]
Dentsply Sirona Declares Quarterly Cash Dividend
22/05/2024
CHARLOTTE, N.C., May 22, 2024 (GLOBE NEWSWIRE) -- DENTSPLY SIRONA Inc. (“Dentsply Sirona” or the "Company") (Nasdaq: XRAY) announced that its Board of Directors declared a quarterly cash dividend of $0.16 per share of [...]
CytomX Therapeutics to Present at the Jefferies Global Healthcare Conference
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of masked, conditionally activated biologic therapeutics, today announced that Sean McCarthy [...]
Soleno Therapeutics Announces Oral Presentation featuring DCCR (Diazoxide Choline) Extended-Release Tablets in Prader-Willi Syndrome at ENDO 2024
22/05/2024
REDWOOD CITY, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO), a clinical-stage biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, [...]
PetMed Express, Inc. Sets Fourth Quarter and Full Fiscal Year 2024 Earnings Call
22/05/2024
DELRAY BEACH, Fla., May 22, 2024 (GLOBE NEWSWIRE) -- PetMed Express, Inc. , dba PetMeds and parent company of PetCareRx, (Nasdaq: PETS) ("PetMeds"), will hold a conference call on Tuesday, June 11, 2024 at 4:30pm [...]
GeneDx to Participate in Upcoming Investor Conferences
22/05/2024
STAMFORD, Conn., May 22, 2024 (GLOBE NEWSWIRE) -- GeneDx (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today announced that company management will participate in two upcoming [...]
Connect Biopharma Presents Late-Breaking Abstract at the American Thoracic Society 2024 International Conference on the Positive Rademikibart Data from its Global Phase 2b in Patients with Moderate-to-Severe Asthma
22/05/2024
Rademikibart treatment significantly improved lung function at Week 12; improvements were observed as early as Week 1 and sustained through Week 24 Significant improvement in patient-reported asthma control occurred [...]
Aligos Therapeutics Announces Six Abstracts Accepted for Presentation at EASL 2024
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics to address unmet [...]
89bio to Present 48-Week Data from ENLIVEN Phase 2b Pegozafermin Trial in Metabolic Dysfunction-Associated Steatohepatitis (MASH) at EASL International Liver Congress
22/05/2024
-Poster presentation selected for the EASL Poster Tour, a dedicated discussion session- SAN FRANCISCO, May 22, 2024 (GLOBE NEWSWIRE) -- 89bio, Inc. (Nasdaq: ETNB), a clinical-stage biopharmaceutical company focused on [...]
BrightSpring Health Services, Inc. to Participate in Three Upcoming Investor Conferences
22/05/2024
LOUISVILLE, Ky., May 22, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. (“BrightSpring” or the “Company”) (NASDAQ: BTSG) announced today that Company management will participate at three upcoming investor [...]
Nyxoah Announces Proposed Offering of Ordinary Shares
22/05/2024
REGULATED INFORMATION INSIDE INFORMATION Nyxoah Announces Proposed Offering of Ordinary Shares Mont-Saint-Guibert, Belgium – May 22, 2024, 10:05pm CET / 4:05pm ET – Nyxoah SA (Euronext Brussels/Nasdaq: NYXH) (“Nyxoah” [...]
Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires
22/05/2024
INFORMATIONS PRIVILÉGIÉES INFORMATIONS RÉGLEMENTÉES Nyxoah Annonce une Proposition d'Offre d'Actions Ordinaires Mont-Saint-Guibert, Belgique – 22 mai 2024, 22h05 CET / 16h05 ET - Nyxoah SA (Euronext Brussels/Nasdaq : [...]
Cytokinetics Announces Proposed Public Offering of Common Stock
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced plans to offer, subject to market and other conditions, approximately $500 million of shares of its [...]
Standard BioTools to Participate in Upcoming Investor Conferences
22/05/2024
SOUTH SAN FRANCISCO, Calif., May 22, 2024 (GLOBE NEWSWIRE) -- Standard BioTools Inc. (“Standard BioTools”) (Nasdaq:LAB) today announced that its management team will participate in the following investor conferences in [...]
Cytokinetics and Royalty Pharma Announce Expanded Strategic Funding Collaboration Totaling Up to $575 Million to Support Commercial Launch of Aficamten and to Advance R&D Pipeline
22/05/2024
Deal Provides Cytokinetics with Diversified Access to Capital as Company Advances Its Specialty Cardiology Franchise SOUTH SAN FRANCISCO, Calif. and NEW YORK, May 22, 2024 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated [...]
Inventiva announces two scientific presentations at the EASL International Liver Congress™ 2024
22/05/2024
The first abstract demonstrates that the improvements of MACK-3, a diagnostic test for metabolic dysfunction-associated steatohepatitis, parallel the histological response to lanifibranor therapy in patients with MASH/ [...]
Inventiva annonce deux présentations scientifiques lors de l’EASL International Liver Congress™ 2024
22/05/2024
Le premier abstract démontre un parallèle entre les améliorations du score MACK-3, un test de diagnostic de la stéatohépatite associée à un dysfonctionnement métabolique, et la réponse histologique au traitement par [...]

Pages